Immune dysfunction, cytokine disruption, and stromal changes in myelodysplastic syndrome: A review

OF Lynch, LM Calvi - Cells, 2022 - mdpi.com
findings suggested a deficiency in osteoblast development, recruitment, or efficiency in the
setting of MDS, suggesting that the function of mesenchymal … and a lack of myelodysplasia, …

Senescent mesenchymal stem cells in myelodysplastic syndrome: functional alterations, molecular mechanisms, and therapeutic strategies

X Chen, N Li, J Weng, X Du - Frontiers in Cell and Developmental …, 2021 - frontiersin.org
… This review may help improve existing knowledge regarding … of MDS and enable new targets
for the treatment of MDS to be … results indicated that dysfunctional MSCs derived from MDS

Bone marrow MSCs in MDS: contribution towards dysfunctional hematopoiesis and potential targets for disease response to hypomethylating therapy

Z Poon, N Dighe, SS Venkatesan, AMS Cheung, X Fan… - Leukemia, 2019 - nature.com
Mesenchymal stromal cells (MSCs) are a principal … We had excluded certain MDS-MSCs
from this analysis due to lack of … In correlating our experimental results with clinical findings, …

Impaired expression of focal adhesion kinase in mesenchymal stromal cells from low-risk myelodysplastic syndrome patients

Y Wu, CM Aanei, S Kesr, T Picot, D Guyotat… - Frontiers in …, 2017 - frontiersin.org
… -MDS stromal microenvironment as compared to those from healthy subjects. At the molecular
level… Contradicting some reports (4, 14), our results revealed that although LR-MDS MSCs …

[PDF][PDF] Mesenchymal stromal cells in myeloid malignancies

T Schroeder, S Geyh, U Germing, R Haas - Blood research, 2016 - synapse.koreamed.org
… Dicer1 in mesenchymal/osteoprogenitor cells resulted in a MDS phenotype … Insufficient
stromal support in MDS results from molecular and functional deficits of mesenchymal stromal

The mesenchymal niche in MDS

E Pronk, MHGP Raaijmakers - Blood, The Journal of the …, 2019 - ashpublications.org
… in vitro–expanded mesenchymal stromal cells, into the marrow … WNT signaling in mesenchymal
cells in MDS may result from … seems to be insufficient experimental support for the view …

Aging-and senescence-associated changes of mesenchymal stromal cells in myelodysplastic syndromes

D Mattiucci, G Maurizi, P Leoni… - Cell …, 2018 - journals.sagepub.com
… MSCs in MDS showing functional and molecular alterations … healthy microenvironment is
not sufficient to improve cytopenias… vivo studies revealed that MDS pathogenesis results from a …

Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support …

G Corradi, C Baldazzi, D Očadlíková, G Marconi… - Stem cell research & …, 2018 - Springer
… Overall, our results elucidated that MDS-MSCs and AML-… mesenchymal stromal cell from
myelodysplastic syndromeMolecular alterations in bone marrow mesenchymal stromal cells …

[HTML][HTML] Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia

S Geyh, M Rodríguez-Paredes, P Jäger, A Koch… - …, 2018 - ncbi.nlm.nih.gov
… Our findings establish transforming growth factor β1 as a … substantially to the inadequate
hematopoiesis in MDS and AML… revealed a specific molecular signature of MDS- and AML-…

Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia

S Geyh, M Rodriguez-Paredes, P Jäger… - Leukemia, 2016 - nature.com
… , as well as for molecular functions associated with transcription regulation (… Insufficient
stromal support in MDS results from molecular and functional deficits of mesenchymal stromal